These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17682436)

  • 1. [Primary liver carcinoid tumor complicated with colon cancer].
    Nagamura N; Andou M; Toyokawa T; Ohnisi T; Nakatu M; Suwaki K; Hirohata M
    Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1473-5. PubMed ID: 17682436
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.
    Molenaar JP; Baten A; Blokx WA; Hoogendam A
    Eur Urol; 2009 Nov; 56(5):874-7; quiz 876. PubMed ID: 19171417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic carcinoid tumor in the liver.
    Dogra VS; Poblete J
    J Clin Ultrasound; 1993; 21(9):639-41. PubMed ID: 8227395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Orthotopic liver transplantation for metastases of bronchial carcinoid tumor].
    Le Hello C; Auvray S; Letellier P; Segol P
    Gastroenterol Clin Biol; 1992; 16(3):281-3. PubMed ID: 1349869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoid of the pancreas.
    Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
    Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of carcinoid tumor with a long-acting somatostatin analog].
    Werling K; Lengyel G; Fehér E; Jakab Z; Besznyák I; Feher J
    Orv Hetil; 1993 Feb; 134(6):301-5. PubMed ID: 8430017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-differentiated gastric carcinoids treated with somatostatin analogues.
    Cuesta Hernández M; Gómez Hoyos E; de Miguel Novoa P; Díaz Pérez JÁ
    Endocrinol Nutr; 2013 Jan; 60(1):41-3. PubMed ID: 22483381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up].
    Igaz P; Rácz K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
    Tohyama T; Matsui K; Kitagawa K
    Intern Med; 2005 Sep; 44(9):958-62. PubMed ID: 16258211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy-induced tumor regression. Morphological findings in malignant primary and secondary liver tumors following intensive regional cytostatic treatment].
    Fischer HP
    Pathologe; 1985 Jan; 6(1):16-23. PubMed ID: 3983083
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analogs of somatostatin and carcinoid tumors].
    Gutiérrez Rodero F; Morales Cano JM; de Blas Laborda C; González Barber A
    Med Clin (Barc); 1990 Jun; 95(2):78-9. PubMed ID: 2250512
    [No Abstract]   [Full Text] [Related]  

  • 12. [Three cases of multiple liver metastases of carcinoid tumor responding to hepatic arterial infusion chemotherapy using degradable starch microspheres].
    Takanashi K; Homma H; Mezawa S; Doi T; Akiyama T; Machida T; Murakami K; Hirata K; Iyama S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2358-61. PubMed ID: 12484074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolent carcinoid tumor of the sigmoid colon.
    Berger JJ; Berman SS; Morgan RE; Britt LD
    Am Surg; 1994 Apr; 60(4):251-4. PubMed ID: 8129244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy.
    Khan MQ; Al Kahtani KM; Al-Ashgar H
    Ann Saudi Med; 2004; 24(5):386-90. PubMed ID: 15573856
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
    Pregun I; Gergics P; Dabasi G; Igaz P; Racz K; Tulassay Z
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):386-7. PubMed ID: 20611009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functioning malignant carcinoid (case report. Preliminary results of treatment with 3 new drugs)].
    Sillero J; De Cañete F; Moreno Quesada A; Salido Sánchez A
    Rev Clin Esp; 1969 Nov; 115(4):287-98. PubMed ID: 4392338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary liver carcinoid tumor confirmed by autopsy].
    Sautner D; Berndt R; Gusek W
    Pathologe; 1988 Mar; 9(2):115-8. PubMed ID: 3362784
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.
    Bondanelli M; Ambrosio MR; Zatelli MC; Cavazzini L; Al Jandali Rifa'y L; degli Uberti EC
    World J Gastroenterol; 2005 Apr; 11(13):2041-4. PubMed ID: 15801004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoid crisis induced by repeated abdominal examination.
    Morrisroe K; Sim IW; McLachlan K; Inder WJ
    Intern Med J; 2012 Mar; 42(3):342-4. PubMed ID: 22432991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.